About C-Bridge Capital

Sponsor retains sole responsibility for content.

C-Bridge Capital is a healthcare dedicated private equity firm, focused on growth and late stage investment opportunities with US$800 million of Assets Under Management. C-Bridge Capital’s current portfolio includes China’s leading players in pharmaceuticals, medical devices, diagnostics and healthcare services. C-Bridge Capital is committed to support commercialization of cutting edge technolog...

C-Bridge Capital is a healthcare dedicated private equity firm, focused on growth and late stage investment opportunities with US$800 million of Assets Under Management. C-Bridge Capital’s current portfolio includes China’s leading players in pharmaceuticals, medical devices, diagnostics and healthcare services. C-Bridge Capital is committed to support commercialization of cutting edge technologies and companies that fulfil unmet medical needs, thus continuously improving the standard and quality of care for patients.

Contact C-Bridge Capital

Phone Number
+86 186 1687 3122

More About C-Bridge Capital

Therapeutic Areas
  • Autoimmune disorders
  • Blood and associated organs
  • Cardiovascular
  • Gastrointestinal
  • Hepatic
  • Infectious
  • Inflammation
  • Oncology
  • Renal
  • Respiratory
Technologies
  • Antimicrobial
  • Biologics
  • Biosimilars
  • Diagnostics
  • Medical device
  • Small molecules
  • Surgery
  • Vaccines
Company Type
  • Investor
State of Ownership
  • Private
Sponsorship Group
  • Partner